Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Title Grant Type Focus Area Country Application Due Date An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient CareRelease Date:Quality Improvement Support for the Professions Senegal PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology China Improving cancer care in patients with metastatic breast cancerRelease Date:Quality Improvement Oncology Kazakhstan An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)Release Date:Education Inflammation & Immunology All Improving Health Equity in IBD through Disparities ResearchRelease Date:Research Inflammation & Immunology All Emerging Science in the Management of Acute Myeloid LeukemiaRelease Date:Education Oncology All Addressing Systemic Drivers of Racial Health InequitiesRelease Date:Quality Improvement Health Equity USA Diversity in Postmarketing Drug Safety SurveillanceRelease Date:Research Patient Safety USA Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient EducationRelease Date:Education Oncology Ghana, Rwanda Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-PacificRelease Date:Education Rare Disease All Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates 2023 Inflammatory Bowel Disease (IBD) Fellowship – IndiaRelease Date:Fellowship Inflammation & Immunology India